This ultimately leads to altered epigenetic marks e.g. the glioma hypermethylator phenotype (G-CIMP) Besides CPEB1, we only observed altered methylation of a few CpG sites in the CPEB3 gene. This evidence concerns the gene CPEB3 and central nervous system cancer.